Vident Advisory’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Vident Advisory's AMPH Position: Q2 2026 in Review
Vident Advisory increased its Amphastar Pharmaceuticals (AMPH) stake by 47% in Q2 2026, buying an estimated $221K and bringing the position to 34,221 shares worth $691K. The position accounts for 0.01% of the portfolio, ranked #1195.
Vident Advisory first reported a position in AMPH in Q2 2025 and has held it in 5 quarters since. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- Vident Advisory held 34,221 shares of Amphastar Pharmaceuticals worth $691K as of Q2 2026.
- Vident Advisory bought 10,977 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $221K.
- Amphastar Pharmaceuticals made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #1195 holding.
- Vident Advisory first reported a position in Amphastar Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.